Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.36B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$236M |
| 3 |
Apple
AAPL
|
+$223M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$222M |
| 5 |
Southern Company
SO
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FON
SPRINT CORP FON COM
FON
|
+$724M |
| 2 |
Pfizer
PFE
|
+$469M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$409M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$407M |
| 5 |
Zoetis
ZTS
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.63% |
| 2 | Healthcare | 4.25% |
| 3 | Technology | 4.18% |
| 4 | Energy | 3.42% |
| 5 | Communication Services | 3.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PGTI
5001
DELISTED
PGT, Inc.
PGTI
| $186K | ﹤0.01% |
20,734
+18,017
| +663% | +$182K |
|
|
CRAY
5002
DELISTED
Cray, Inc.
CRAY
| $186K | ﹤0.01% |
7,762
+2,545
| +49% | +$62K |
|
|
IM
5003
CALL
DELISTED
Ingram Micro
IM
| $186K | ﹤0.01% |
+8,100
| New | +$179K |
|
|
IDIX
5004
CALL
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
| $186K | ﹤0.01% |
37,200
-14,500
| -28% | -$63.5K |
|
|
RTI
5005
PUT
DELISTED
RTI INTL METALS INC(HLDG CO)
RTI
| $186K | ﹤0.01% |
5,800
-6,400
| -52% | -$199K |
|
5006
CALL
Avery Dennison
AVY
$13.2B
| $185K | ﹤0.01% |
4,300
-54,300
| -93% | -$2.41M |
|
5007
PUT
Brookfield
BN
$108B
| $185K | ﹤0.01% |
21,357
-19,648
| -48% | -$168K |
|
5008
CALL
FormFactor
FORM
$9B
| $185K | ﹤0.01% |
30,800
| – | – |
|
5009
CALL
iShares Europe ETF
IEV
$1.69B
| $185K | ﹤0.01% |
4,200
+3,200
| +320% | +$135K |
|
|
5010
PUT
iShares Europe ETF
IEV
$1.69B
| $185K | ﹤0.01% |
4,200
+2,000
| +91% | +$84.3K |
|
|
MODV
5011
DELISTED
ModivCare
MODV
| $185K | ﹤0.01% |
6,629
+2,357
| +55% | +$66.3K |
|
5012
CALL
Strategy Inc
MSTR
$37.2B
| $185K | ﹤0.01% |
18,000
-83,000
| -82% | -$808K |
|
5013
PUT
Red Robin
RRGB
$156M
| $185K | ﹤0.01% |
2,600
+2,300
| +767% | +$144K |
|
5014
PUT
ProShares UltraShort Materials
SMN
$3.88M
| $185K | ﹤0.01% |
275
+81
| +42% | +$59.8K |
|
5015
CALL
Dentsply Sirona
XRAY
$2.64B
| $185K | ﹤0.01% |
4,300
-2,700
| -39% | -$115K |
|
|
CSH
5016
PUT
DELISTED
CASH AMERICA INTERNATIONAL INC
CSH
| $185K | ﹤0.01% |
9,036
-1,764
| -16% | -$35.1K |
|
|
CYBX
5017
PUT
DELISTED
CYBERONICS INC
CYBX
| $185K | ﹤0.01% |
3,700
-7,800
| -68% | -$409K |
|
|
RC
5018
Ready Capital
RC
$279M
| $184K | ﹤0.01% |
10,799
+10,330
| +2,203% | +$175K |
|
|
RDUS
5019
PUT
DELISTED
Radius Recycling
RDUS
| $184K | ﹤0.01% |
6,800
-27,800
| -80% | -$728K |
|
5020
CALL
Steel Dynamics
STLD
$37.5B
| $184K | ﹤0.01% |
11,500
-16,400
| -59% | -$260K |
|
|
SRCL
5021
PUT
DELISTED
Stericycle Inc
SRCL
| $184K | ﹤0.01% |
1,600
-3,700
| -70% | -$427K |
|
|
TRK
5022
DELISTED
Speedway Motorsports, Inc.
TRK
| $184K | ﹤0.01% |
10,824
-803
| -7% | -$14.8K |
|
|
YGE
5023
CALL
DELISTED
Yingli Green Energy Holding Comp
YGE
| $184K | ﹤0.01% |
3,060
+630
| +26% | +$28.3K |
|
|
SPNC
5024
DELISTED
Spectranetics Corp
SPNC
| $184K | ﹤0.01% |
11,521
+2,623
| +29% | +$45.7K |
|
5025
BioCryst Pharmaceuticals
BCRX
$2.38B
| $183K | ﹤0.01% |
26,090
-143,196
| -85% | -$726K |
|
Similar funds
Barclays's Q3 2013 Portfolio in Review
As of Q3 2013, Barclays held 8,017 positions worth $83.8B, up 4.2% from $80.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays's Q3 2013 filing shows 302 new, 3,328 increased, 3,470 reduced and 580 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M. The largest sale was SPRINT CORP FON COM, an estimated $724M.
By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 4.5% a quarter earlier, followed by Healthcare and Technology.
- Barclays's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M.
- Barclays added most to iPath ETNs Linked to the MSCI India Total Return Index in Q3 2013, an estimated $1.36B increase.
- Barclays's biggest Q3 2013 reduction was Pfizer, cutting an estimated $469M.
- Barclays fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $724M.
- Barclays's ten largest holdings make up 26% of its $83.8B portfolio in Q3 2013.
- Barclays opened 302 new positions and closed 580 in Q3 2013.
- Barclays's portfolio value rose 4.2% quarter-over-quarter to $83.8B.
Based on Barclays's 13F filing for Q3 2013, filed 14 Nov 2013.